David J. Spalding

702 total citations
21 papers, 579 citations indexed

About

David J. Spalding is a scholar working on Pharmacology, Pharmacology and Organic Chemistry. According to data from OpenAlex, David J. Spalding has authored 21 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 8 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in David J. Spalding's work include Inflammatory mediators and NSAID effects (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). David J. Spalding is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Drug Transport and Resistance Mechanisms (4 papers). David J. Spalding collaborates with scholars based in United Kingdom, Netherlands and Sweden. David J. Spalding's co-authors include Anders Rane, Beverley Hammond, Margarita G. Ladona, Oscar Della Pasqua, Dymphy Huntjens, Scott Summerfield, Meindert Danhof, Anne Hersey, Leanne Cutler and Sac-Pham Tang and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

David J. Spalding

21 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Spalding United Kingdom	13	169	169	154	138	100	21	579
Louis Leung United States	16	163 1.0×	287 1.7×	195 1.3×	124 0.9×	74 0.7×	24	754
Paul Weller United States	14	114 0.7×	196 1.2×	309 2.0×	212 1.5×	167 1.7×	19	867
Yoshiyuki Yamaura Japan	16	247 1.5×	241 1.4×	253 1.6×	80 0.6×	74 0.7×	38	826
Rebecca B. White United States	14	124 0.7×	218 1.3×	198 1.3×	81 0.6×	181 1.8×	27	636
Iain Martin United Kingdom	16	147 0.9×	138 0.8×	235 1.5×	80 0.6×	167 1.7×	26	651
Madeleine Antonsson Sweden	14	333 2.0×	175 1.0×	280 1.8×	86 0.6×	71 0.7×	20	1.1k
Shawn D. Doran United States	16	213 1.3×	54 0.3×	272 1.8×	87 0.6×	149 1.5×	20	747
Kazutomi Kusano Japan	20	241 1.4×	269 1.6×	310 2.0×	116 0.8×	44 0.4×	46	902
Kristian T. Hansen Denmark	12	157 0.9×	224 1.3×	256 1.7×	81 0.6×	45 0.5×	18	666
Loren Berry United States	13	132 0.8×	237 1.4×	284 1.8×	86 0.6×	44 0.4×	20	694

Countries citing papers authored by David J. Spalding

Since Specialization

Citations

This map shows the geographic impact of David J. Spalding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Spalding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Spalding more than expected).

Fields of papers citing papers by David J. Spalding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Spalding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Spalding. The network helps show where David J. Spalding may publish in the future.

Co-authorship network of co-authors of David J. Spalding

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Spalding. A scholar is included among the top collaborators of David J. Spalding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Spalding. David J. Spalding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Healy, Mark P., Andy Billinton, Iain P. Chessell, et al.. (2018). Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 28(10). 1892–1896. 4 indexed citations

Bamford, Mark J., Emmanuel H. Demont, Richard L. Elliott, et al.. (2009). Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs). Bioorganic & Medicinal Chemistry Letters. 19(13). 3602–3606. 12 indexed citations

Huntjens, Dymphy, David J. Spalding, Meindert Danhof, & Oscar Della Pasqua. (2009). Impact of chronic inflammation on the pharmacokinetic–pharmacodynamic relationship of naproxen. European Journal of Pain. 14(3). 227.e1–10. 5 indexed citations

Huntjens, Dymphy, David J. Spalding, Meindert Danhof, & Oscar Della Pasqua. (2008). Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo‐oxygenase inhibitors. European Journal of Pain. 13(5). 448–457. 22 indexed citations

Huntjens, Dymphy, Anne Chain, Scott Summerfield, et al.. (2008). Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. British Journal of Pharmacology. 153(5). 1072–1084. 24 indexed citations

Hall, Adrian, Rino A. Bit, Susan H. Brown, et al.. (2006). Discovery of novel biaryl heterocyclic EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2666–2671. 16 indexed citations

Summerfield, Scott, Alexander J. Stevens, Leanne Cutler, et al.. (2006). Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1282–1290. 138 indexed citations

Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(3). 732–735. 9 indexed citations

Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(4). 916–920. 12 indexed citations

10.

Huntjens, Dymphy, David J. Spalding, Meindert Danhof, & Oscar Della Pasqua. (2006). Correlation betweenin vitroandin vivoconcentration–effect relationships of naproxen in rats and healthy volunteers. British Journal of Pharmacology. 148(4). 396–404. 34 indexed citations

11.

Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3657–3662. 21 indexed citations

12.

Giblin, Gerard M.P., Rino A. Bit, Susan H. Brown, et al.. (2006). The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 17(2). 385–389. 42 indexed citations

13.

Witherington, Jason, Vincent Bordas, Richard L. Elliott, et al.. (2006). Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5538–5541. 6 indexed citations

14.

Cockerill, Stuart, Colin Stubberfield, Jeremy N. Stables, et al.. (2001). Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2. Bioorganic & Medicinal Chemistry Letters. 11(11). 1401–1405. 63 indexed citations

15.

Spalding, David J., et al.. (2000). Combining high-throughput pharmacokinetic screens at the hits-to-leads stage of drug discovery. Drug Discovery Today. 5(12). 70–76. 9 indexed citations

16.

Burke, Dermot, et al.. (1994). Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing. Mutagenesis. 9(1). 23–29. 26 indexed citations

17.

Gerdin, Eva, David J. Spalding, Bo Lindberg, & Anders Rane. (1991). Glucuronidation of Morphine and some Drug Oxidation Reactions in Liver Microsomes from Pregnant and Non‐Pregnant Rhesus Monkeys. Pharmacology & Toxicology. 69(1). 78–80. 2 indexed citations

18.

Waye, Kerstin Persson, et al.. (1990). Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: Relationship to the presence of immunoidentified cytochrome P-450IID1. Clinical Pharmacology & Therapeutics. 47(1). 27–35. 71 indexed citations

19.

Lindström, Björn, et al.. (1989). Determination of codeine and its metabolites in human blood plasma and in microsomal incubates by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 491(2). 473–480. 16 indexed citations

20.

Ladona, Margarita G., et al.. (1989). Human fetal and adult liver metabolism of ethylmorphine. Biochemical Pharmacology. 38(19). 3147–3155. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact